In summary, the use of immune agonists and TME-modulating agents not only amplifies immediate effector responses but also, more importantly, orchestrates the immune system toward the establishment of durable AIM, a paradigm shift essential for overcoming adaptive resistance in cancer immunotherapy
Refractory SLE patients respond to the proteasome inhibitor bortezomib
Some people may start to feel different within hours of their first injection, while others may require a few weeks and several injections to really start to see a difference
A meta-analysis of 42,920 participants from five randomized trials demonstrated that GLP-1 RAs are associated with a significant reduction in the risk of the composite cardiovascular disease in patients with diabetes and established ASCVD [53]
Malondialdehyde, a byproduct of lipid peroxidation, is a marker for both ferroptosis and oxidative stress (56)